Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Trends
- Key Insights
- Number of Phase IV Clinical Trials - by Key Countries, 2022
- Overview of Regulatory Scenario
- Overview: Use of AI in Clinical Trial Designs
- Impact of AI and Big Data Technology use in Clinical Trials
- Key Industry Developments (Mergers, Acquisitions, Collaborations, etc.)
- Impact of COVID-19 on the Market
- Europe Phase IV Clinical Trials Market Analysis, Insights and Forecast, 2019-2030
- Market Analysis, Insights and Forecast – By Deployment
- In-house
- Outsource
- Market Analysis, Insights and Forecast – By Disease Indication
- Oncology
- Neurology
- Cardiology
- Infectious Disease
- Metabolic Disorder
- Renal/Nephrology
- Others
- Market Analysis, Insights and Forecast – By Type
- Interventional
- Non-interventional
- Market Analysis, Insights and Forecast – By Country/Sub-region
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Competitive Analysis
- Global Market Share Analysis (2022)
- Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- IQVIA Inc.
- Overview,
- Services,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- Parexel International (MA) Corporation
- Overview,
- Services,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- ICON plc
- Overview,
- Services,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- Laboratory Corporation of American Holdings
- Overview,
- Services,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- Charles River Laboratories
- Overview,
- Services,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- PHASTAR
- Overview,
- Services,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- PSI
- Overview,
- Services,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- MedpaceHoldings, Inc.
- Overview,
- Services,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- Worldwide Clinical Trials
- Overview,
- Services,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- ProRelix Services LLP
- Overview,
- Services,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- Sofpromed
- Overview,
- Services,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
List of Figures
Figure 01: Europe Phase IV Clinical Trials Market Revenue Breakdown (USD billion, %) by Region, 2022 & 2030
Figure 02: Europe Phase IV Clinical Trials Market Value Share (%), By Deployment, 2022 & 2030
Figure 03: Europe Phase IV Clinical Trials Market Value Share (%), By Disease Indication, 2022 & 2030
Figure 04: Europe Phase IV Clinical Trials Market Value Share (%), By Type, 2022 & 2030
Figure 05: Europe Phase IV Clinical Trials Market Value (USD billion), By Country/Sub-region, 2022 & 2030
Figure 06: Europe Phase IV Clinical Trials Market Share (%), 2022
List of Tables:
Table 01: Europe Phase IV Clinical Trials Market Revenue (USD billion) Forecast, By Deployment, 2019–2030
Table 02: Europe Phase IV Clinical Trials Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2030
Table 03: Europe Phase IV Clinical Trials Market Revenue (USD billion) Forecast, By Type, 2019–2030
Table 04: Europe Phase IV Clinical Trials Market Revenue (USD billion) Forecast, By Country/Sub-region, 2019–2030